Laminopathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-04-07
EMA Authorised: Zokinvy (Lonafarnib) — TMC Pharma (EU) Limited
The European Medicines Agency authorised Zokinvy (lonafarnib) for Hutchinson-Gilford progeria syndrome and laminopathies in the European Uni…